💊 J&J halts Covid-19 vaccine production, Pfizer predicts another bumper year, Deloitte expands, BioSplice contracts, #HKhamsters report from the ether

Feb 09, 2022

∙ Paid

Thank god it’s Wednesday. Which means only two more days to the weekend. And thinking about vaccine inequity. Which is covered in today’s issue. Along with news from the anti-aging space. And approvals and investments in and from India. And Deloitte applying healthcare learning to consumer services.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.